InterCure Ltd.
INCR
$1.35
-$0.03-2.17%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -8.57% | -22.33% | -33.48% | -36.54% | -38.20% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -8.57% | -22.33% | -33.48% | -36.54% | -38.20% |
| Cost of Revenue | 6.44% | -9.54% | -20.94% | -24.87% | -28.39% |
| Gross Profit | -45.96% | -53.77% | -61.80% | -57.87% | -53.93% |
| SG&A Expenses | 15.19% | 13.21% | 11.11% | -4.36% | -20.64% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 295.47% | 552.26% | 93.74% | -93.95% | -139.45% |
| Total Operating Expenses | 25.05% | 6.47% | -8.86% | -26.88% | -35.65% |
| Operating Income | -8,152.87% | -28,792.04% | -12,584.79% | -464.16% | -107.16% |
| Income Before Tax | -49.98% | -46.05% | -45.55% | -92.01% | -1,106.86% |
| Income Tax Expenses | -411.62% | -1,404.36% | -758.78% | 68.19% | 142.40% |
| Earnings from Continuing Operations | -12.97% | -18.34% | -17.04% | -189.62% | -456.56% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 112.05% | 97.48% | 214.17% | -31.87% | -52.50% |
| Net Income | -10.31% | -15.45% | -11.86% | -247.40% | -390.16% |
| EBIT | -8,152.87% | -28,792.04% | -12,584.79% | -464.16% | -107.16% |
| EBITDA | -881.35% | -810.42% | -734.40% | -2,075.18% | -59.98% |
| EPS Basic | -11.64% | -16.36% | -13.25% | -240.15% | -400.31% |
| Normalized Basic EPS | -510.74% | -444.61% | -444.27% | -165.53% | -2,103.33% |
| EPS Diluted | -11.74% | -16.47% | -13.36% | -240.49% | -400.39% |
| Normalized Diluted EPS | -510.74% | -444.61% | -444.27% | -166.47% | -2,348.15% |
| Average Basic Shares Outstanding | 8.85% | 2.81% | 0.65% | 0.78% | 0.94% |
| Average Diluted Shares Outstanding | 8.85% | 2.81% | 0.65% | 0.66% | 0.82% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |